proof of concept ulcerative colitis Pages on BioPortfolio:

BioPortfolio - proof of concept ulcerative colitis
proof of concept ulcerative colitis Pages on BioPortfolio: ... Ulcerative colitis. Reflux inhibitor. Reflux disease. Proof of concept. ...
http://www.bioportfolio.com/search/proof_of_concept_ulcerati...

Biotechnology News Search
(NASDAQ:SLXP) today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis (UC) patients who
switched ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=ne...

BioPortfolio - Ulcerative Colitis
Ulcerative Colitis - BioPortfolio - Indepth. ... biovu provides a unique, commercial, client-focused, ‘proof-of-concept’ medical imaging service in
patients ...
http://www.bioportfolio.com/indepth/Ulcerative_Colitis.html...

BioPortfolio - Biovu
biovu provides a unique, commercial, client-focused, ‘proof-of-concept’ medical ... e.g. rheumatoid arthritis, ulcerative colitis and Crohn’s disease, ...
http://www.bioportfolio.com/biocorporate/2010-Biovu.html...

BioPortfolio - Biovu
BioPortfolio - proof of concept ulcerative colitis Ulcerative Colitis - BioPortfolio - Indepth. ... biovu provides a unique, ... What Is the Maximum
Dose of ...
http://www.bioportfolio.com/search/Biovu.html...

Biotechnology and Pharmaceutical News Site Map
... Phase IIa clinical trial with Alkaline Phosphatase for ulcerative colitis .... Molecular Therapeutics BV to present preclinical proof-of-concept data on
...
http://www.bioportfolio.com/biotech_news/site_map.htm...

BioPortfolio - Biovu - Profile
... e.g. rheumatoid arthritis, ulcerative colitis and Crohn’s disease, where the ... whole body imaging capability can demonstrate ‘proof of concept’ in a ...
http://www.bioportfolio.com/biocorporate/2010-Biovu.pdf...

AM-Pharma announces appointment of new VP Clinical Development
Now that Proof of Concept has been established for bovine derived Alkaline Phosphatase in Acute Renal Failure and Ulcerative Colitis, AM-Pharma has started
...
http://www.bioportfolio.com/biotech_news/AM_Pharma_6.htm...

La Merie R&D Pipeline News Therapeutic Edition Sample
Proof-of-concept. BLA. Biologics License Agreement. Drug Delivery .... FDA approved use of Remicade in ulcerative colitis, the 5th approved indication read
...
http://www.bioportfolio.com/promote/Therapeutic%20Edition%20...

La Merie R&D Update: July 18, 2005
Proof-of-concept. Natural Source ..... ulcerative colitis. sBLA. FDA approved use of Remicade in. ulcerative colitis, the 5 ...
http://www.bioportfolio.com/pdf/R&D_Pipeline_News_Technology...

Results from other life science and pharmaceutical sites:

BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
Hutchison China MediTech (Chi-Med) Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis 7/2/2007 More. ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

Serono and Swedish Biotech Company InDex Pharmaceuticals Sign ...
"Ulcerative colitis is a severe debilitating disease and represents a high ... In a completed proof-of-concept, double-blind placebo-controlled clinical ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Shire Laboratories Receives Label Agreement In Europe For ...
14 Dec 2006 ... Mezavant is the only ulcerative colitis treatment that utilizes novel ... Giuliani S.p.A. has developed Mezavant from proof of concept to ...
http://www.biospace.com/news_story.aspx?NewsEntityId=40206...

Retarded release phosphatidylcholine benefits patients with ...
Keywords: ulcerative colitis, lipid based therapy, phosphatidylcholine, ..... our results from the present proof of concept study (phase IIA) indicate that
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17...

Nicotine fix - Nature Medicine
Proof-of-concept studies suggest that delivering nicotine via transdermal patches can relieve ulcerative colitis symptoms, albeit with a lot of side
effects ...
http://www.nature.com/nm/journal/v10/n7/full/nm0704-660.html...

Microsoft PowerPoint - JPM Conf - Shire - Jan 10 2007.ppt
active ulcerative colitis and for maintenance of remission. ... Three research projects to proof of concept every 18 months. Principles: ...
http://www.shire.com/shire/uploads/presentations/JPMorgan200...

Advances in Nonbiologic Therapy for Inflammatory Bowel Disease
Previously, in proof-of-concept studies, phosphatidylcholine* was shown to improve disease activity in ulcerative colitis patients and to allow for steroid
...
http://www.medscape.com/viewarticle/576514...

CIRM: RFA 07-04 Summaries of Review Reports: DT1-00699-1
This approach gained proof of concept when AD patients with diseases such as ... amyotrophic lateral sclerosis, Crohn's disease, ulcerative colitis, ...
http://www.cirm.ca.gov/RFA/rfa_07-04/DT1-00699-1.asp...

Retarded Release Phosphatidylcholine a new therapeutic concept for ...
Phosphatidylcholine. a new therapeutic concept for. treatment of chronic active. ulcerative colitis ... in ulcerative colitis (proof of principle) ...
https://www.drfalkpharma.de/fileadmin/media/praesentationen/...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.